ORKAOruka Therapeutics, Inc.

$99.48

Who owns ORKA

184 institutions reported holding ORKA for 2026Q1, together 104% of the company, more than the 142 a quarter earlier.

184

Institutions reporting a position · as of 2026Q1 · up from 142 the quarter before

Shares held by institutions
52.0M

Shares held by institutions · 104% of the company · long US equity positions only, as reported on Form 13F

Reported value
$2.57B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
43%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
7
New positions
56
Positions exited
21
Added to
61
Reduced
30
Top 10 holdersof the company
64%
Institutional ownership by quarter, 2024Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q118452.0M$2.57B
2025Q414252.8M$1.60B
2025Q310445.6M$876M
2025Q28034.4M$386M
2025Q17131.8M$326M
2024Q46631.0M$607M
2024Q34224.6M$604M
Largest reported holders, 2026Q1
HolderShares% of companyValue
FMR LLC7.4M15%$365M
Venrock Adviser, LLC4.1M8.3%$203M
Fairmount Funds Management LLC3.7M7.4%$182M
BlackRock Inc.3.5M7.0%$173M
VIKING GLOBAL INVESTORS LP2.7M5.3%$131M
VANGUARD GROUP INC2.5M5.0%$123M
Paradigm Biocapital Advisors LP2.3M4.6%$114M
RTW INVESTMENTS, LP2.1M4.1%$101M
Deep Track Capital, LP2.0M4.1%$100M
STATE STREET CORP1.6M3.2%$79M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…